Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Verotoxin eliminates astrocytoma tumors in mouse model

July 7, 1999

LG Chemical presents wide series of imidazoles useful as inhibitors of protein farnesyltransferase

July 6, 1999

Search for therapeutically effective protein farnesyltransferase inhibitors continues at Merck

July 6, 1999

Taiho obtains exclusive worldwide rights to potential breast cancer treatment

July 6, 1999

FDA approves initiation of Progen's phase I trial in Australia for PI-88

July 6, 1999

EntreMed extends angiogenesis research agreement with Children's Hospital of Boston

July 6, 1999

Alsterpaullone is a potent CDK1/cyclin B inhibitor and antitumor agent

July 5, 1999

Onyvax and Erasmus University reach prostate cancer agreement

July 5, 1999

The Liposome Company seeks approval for Evacet in the E.U.

July 2, 1999

NA-22598B1 and B2: novel anticancer compounds produced by Streptomyces

July 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...